TriSalus Life Sciences, Inc. (TLSI) Q1 2024 Annual Earnings
TLSI·Reported May 15, 2024·Before market open
TriSalus Life Sciences, Inc. reported Q1 2024 revenue of $6.5M, beat analyst consensus of $6.2M by $289.0K. Diluted EPS came in at $-0.54, beat the $-0.65 consensus by $0.11.
Revenue
$6.5Mbeat by $289.0K
Consensus: $6.2MDiluted EPS
$-0.54beat by $0.11
Consensus: $-0.65
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about TriSalus Life Sciences, Inc.'s Q1 2024 earnings report.
TriSalus Life Sciences, Inc. (TLSI) reported Q1 2024 earnings on May 15, 2024 before market open.
TriSalus Life Sciences, Inc. reported revenue of $6.5M and diluted EPS of $-0.54 for Q1 2024.
Revenue beat the consensus estimate of $6.2M by $289.0K. EPS beat the consensus estimate of $-0.65 by $0.11.
You can read the 10-K periodic report (0001826667-24-000005) directly on SEC EDGAR. The filing index links above go to sec.gov.